Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): phar ...
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): phar ...
Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification code 10008906;Term: Chronic granulomatous disease Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification cod ...
Trade Name: Noxafil 40 mg/ml oral solution Product Name: noxafil INN or Proposed INN: POSACONAZOLE
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): phar ...
Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): pharmacokinetics and tolerability (iPOD) - iPOD Investigation of posaconazole prophylaxis in children with chronic granulomatous disease (CGD): phar ...
Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification code 10008906;Term: Chronic granulomatous disease Children with chronic granulomatous disease (CGD). MedDRA version: 9.1;Level: LLT;Classification cod ...